SFG
PACB icon

SVB Financial Group’s Pacific Biosciences PACB Stock Holding History

SVB Financial Group’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-20,586
Closed -$28.2K – 5
2024
Q2 		$28.2K Hold
20,586
– – 0.02% 10
2024
Q1 		$77.2K Hold
20,586
– – 0.04% 11
2023
Q4 		$202K Buy
20,586
+10,337
+101% +$84.5K 0.18% 9
2023
Q3 		$85.6K Hold
10,249
– – 0.16% 15
2023
Q2 		$136K Hold
10,249
– – 0.26% 15
2023
Q1 		$119K Hold
10,249
– – 0.23% 19
2022
Q4 		$83.8K Buy
+10,249
New +$88.3K 0.23% 24

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

SVB Financial Group's PACB Position: Q3 2024 in Review

SVB Financial Group sold out of Pacific Biosciences (PACB) in Q3 2024, closing a stake of 20,586 shares — an estimated $28.2K sold.

SVB Financial Group first reported a position in PACB in Q4 2022 and held it in 7 quarters. The position peaked at $202K in Q4 2023. 226 funds tracked by Wall St. Rank hold PACB as of Q3 2024.

  • SVB Financial Group reported no remaining Pacific Biosciences position as of Q3 2024 after selling out during the quarter.
  • SVB Financial Group sold 20,586 Pacific Biosciences shares in Q3 2024, an estimated $28.2K.
  • SVB Financial Group first reported a position in Pacific Biosciences in Q4 2022 and held it in 7 quarters.
  • SVB Financial Group's Pacific Biosciences position peaked at $202K in Q4 2023.
  • 226 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2024.

Based on SVB Financial Group's 13F filing for Q3 2024, filed 12 Nov 2024.